Aamaxan Transport Group IncOver The Counter Market:AAXT
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aamaxan Transport Group Inc | 1.6K | 0.0x | --- |
STRATA Skin Sciences Inc | 18.6M | -1.7x | --- |
Dynatronics Corp | 2.8M | -0.4x | --- |
Bionano Genomics Inc | 39.7M | -0.1x | --- |
Cytosorbents Corp | 43.9M | -1.3x | --- |
Telesis Bio Inc | 9.7M | -0.2x | --- |
Company Information
Aamaxan Transport Group, Inc. is a shell company as it has no or nominal operations. Aamaxan was dormant from mid-2000 until recently. The Company has been seeking, and will continue to seek, potential operating businesses and business opportunities with the intent to acquire or merge with such businesses. It is considered a development stage company and its principal purpose is to locate and consummate a merger or acquisition with a private entity. Effective April 15, 2008, the Company has completed the acquisition of Asian Business Management Group Limited (ABM). ABM, through its direct and indirect subsidiaries, including Shanghai Medical Technology Co., Ltd. (Shanghai Medical), a PRC company, is the provider of Hemodialysis equipment (HDE) and other related supplies and services, including disposable and diagnostic products and pharmaceuticals, throughout Eastern China.
Contact Information
- Headquarters
- Suite 6B 1440 Hongqiao Road, Changning DistrictSHANGHAI, SHA, China 200336
- Phone
- 215-080-5789
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Zhong Chen
- Acting Chief Financial Officer
- Yifei Xu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6K |
|---|---|
Revenue (TTM) | $39.1M |
Shares Outstanding | 16.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $44.02 |
Book Value | $94.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | 27.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
